by Jim Oldfield, University of Toronto Illustration of bacteria in the human gut. Credit: Darryl Leja, National Human Genome Research Institute, National Institutes of Health An international team led by a University of Toronto researcher has found that an antibody detectable in blood predicts severe Crohn’s disease and is detectable up to seven years prior...
NATIONAL UNIVERSITY OF IRELAND GALWAY IMAGE: EMER MCGRATH, ASSOCIATE PROFESSOR AT THE COLLEGE OF MEDICINE NURSING AND HEALTH SCIENCES AT NUI GALWAY AND CONSULTANT NEUROLOGIST AT SAOLTA UNIVERSITY HEALTH CARE GROUP. CREDIT: AENGUS MCMAHON New research from NUI Galway and Boston University has identified a blood biomarker that could help identify people with the earliest...
MAYO CLINIC JACKSONVILLE, Fla. — A test of protein in the blood gets further support as a biomarker for patients diagnosed with frontotemporal dementia (FTD), a group of brain disorders with few treatment options. These disorders are characterized by changes in behavior, cognition, language or movement. In a new paper published in Cell Reports Medicine, Mayo Clinic researchers and members of the Advancing...
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO SAN ANTONIO (March 24, 2022) — Blood levels of a biomarker called glial fibrillary acidic protein (GFAP) may uniquely aid prediction of dementia in Mexican Americans, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and collaborating institutions reported March 24. The...
by Lund University Fig. 1: Kaplan–Meier curve to illustrate incidence of diabetes in relation to follistatin quartiles. Time axis was follow-up time until death, emigration, incident diabetes or end of follow-up (n = 4195; p = 1.01E-7; two-sided log-rank test). Credit: DOI: 10.1038/s41467-021-26536-w A large study led by Lund University in Sweden has identified a protein in the blood...
by Queensland University of Technology Credit: Unsplash/CC0 Public Domain Dr. Kulasinghe, from QUT Centre for Genomics and Personalised Health and School of Biomedical Sciences, delivered the findings to a special virtual meeting of the American Association of Cancer Research (AACR) on “COVID-19 and Cancer” earlier this month. He said results of the test could inform doctors those patients...
Protective effects of azithromycin treatment in patients highlight the clinical utility of measuring telomere length, according to a new study in the journal CHEST® Glenview, IL, July 12, 2018 – Some patients with COPD demonstrate signs of accelerated aging. In a new study published in the journal CHEST® researchers report that measuring blood telomeres, a marker of aging of cells,...
A blood test for determining the subtype of MS could be as little as two years away following the discovery of a blood biomarker Although there is no known cure for multiple sclerosis (MS), there are treatments that can help prevent new attacks and improve function after an attack. However, there are three subtypes of...
